Recombinant Bovine Ovarian cancer G-protein coupled receptor 1 (GPR68)

Research Applications in Cancer Biology

GPR68 is implicated in tumor microenvironment (TME) acidosis, influencing cancer progression and metastasis. While most studies focus on human or murine GPR68, the bovine recombinant form serves as a comparative model for studying interspecies conservation of receptor function.

Key Research Findings

1. Proton Sensing and Signaling

   • GPR68 activates at pH <6.8, triggering Gαq/11-coupled pathways that elevate intracellular Ca²⁺ and activate protein kinase C (PKC) and mitogen-activated protein kinase (MAPK) .

   • Structural studies using bovine GPR68 may elucidate conserved motifs critical for proton binding and G-protein coupling.

2. Tumor Suppressive vs. Oncogenic Roles

   • Tumor Suppression: Overexpression in prostate cancer cells inhibits migration without affecting proliferation .

   • Oncogenic Effects: Promotes angiogenesis and immune evasion in melanoma by inhibiting CD8⁺ T-cell and NK-cell infiltration .

3. Gender-Specific Modulation

   • GPR68 deficiency reduces melanoma growth in male mice but not females, correlating with enhanced immune cell infiltration (CD45⁺, CD8⁺ T cells, NK cells) .

   • Bovine models could explore evolutionary conservation of these gender-dependent mechanisms.

Table 1: Functional Roles of GPR68 in Cancer

Signaling Pathways

• Gαq/11 Activation: Triggers phospholipase C (PLC)-mediated IP3 production and Ca²⁺ mobilization .

• MAPK Pathway: Regulates cell proliferation and survival under acidic conditions .

Targeting GPR68 in Cancer Therapy

1. Radiosensitization

   • Inhibiting GPR68 (e.g., with OGM) enhances radiosensitivity by inducing ferroptosis via lipid peroxidation and iron dysregulation .

   • Bovine GPR68 models could validate species-specific responses to small-molecule inhibitors.

2. Immune Modulation

   • GPR68 antagonists may restore anti-tumor immunity by increasing CD8⁺ T-cell and NK-cell infiltration .

   • Bovine studies could inform cross-species immune checkpoint strategies.

3. Biomarker Potential

   • GPR68 expression correlates with molecular subtypes (e.g., triple-negative breast cancer) .

   • Recombinant bovine GPR68 may aid in developing antibodies for diagnostic assays.

Challenges and Future Directions

1. Species-Specific Variability

   • Structural differences between bovine and human GPR68 may limit translational relevance.

   • Comparative studies using recombinant proteins could identify conserved motifs for drug design.

2. TME Complexity

   • Acidosis in tumors requires integration of GPR68 with other proton sensors (e.g., GPR4, GPR65).

   • Bovine models may clarify hierarchical roles of these receptors.

3. Gender Disparities

   • Mechanisms underlying male-specific GPR68 effects in melanoma warrant further investigation .